from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3375/amiD

LFCtreatmentdescriptionclass of inhibitor

-0.006

Amikacinug/mL Amikacintranslation

0.913

Cap5-10ug/mL Capreomycintranslation

0.663

Rox10-50 ug/mL Roxithromycintranslation

0.118

SM2-5 ug/mL Streptomycintranslation

1.452

Tet5-10 ug/mL Tetracyclinetranslation

-0.295

Rif0.2-5ug/mL Rifampicintranscription

-0.337

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.761

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.440

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.128

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.303

Clofazimine10-13 ug/mL Clofaziminerespiration

0.197

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.837

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.828

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.179

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.102

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.772

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.088

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.834

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.270

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.676

KCN5-20 ug/mL Potassium cyaniderespiration

1.124

NaN30.2-2 mM Sodium aziderespiration

0.550

Nigericin50 uM Nigericinrespiration

-0.310

TRC10-150 ug/mL Triclosanrespiration

-1.251

TRZ10-25 ug/mL Thioridazinerespiration

-0.856

Valinomycin0.5-10 uM Valinomycinrespiration

2.019

ZnSO42 mM ZnSO4respiration

0.409

menadione6-10 ug/mL Menadionerespiration

0.041

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.428

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.062

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.445

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.591

NRP_1Non-replicating persistence stage 1dosRassociated

0.489

Amp0.2mg/mL AmpicillincellWall

0.116

Cephalexin20-100 ug/mL CephalexincellWall

0.063

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.309

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.620

EMB10-20 ug/mL EthambutolcellWall

1.009

Eta12-40 ug/mL EthionamidecellWall

1.399

INH0.2-0.4 ug/mL IsoniazidcellWall

0.500

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.568

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.382

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.369

BZA0.12 mg/mL BenzamidearomaticAmides

-0.058

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.372

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.758

H2O24 mM hydrogen peroxideDNAdamaging

0.177

Levo10 ug/mL LevofloxacinDNAdamaging

-0.477

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.851

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.232

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.248

UVUV-irradiationDNAdamaging

-0.962

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.206

Antimycin12.5-50 ug/mL Antimycin A?

0.495

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.044

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.425

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.051

PA8240.2-2 ug/mL PA-824?

1.592

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.855

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.475

Verapamil50 uM Verapamil?

0.364

mercaptoethanol2 mM 2-Mercaptoethanol?

0.586

methoxatin10-20 ug/mL Methoxatin?